Abstract
Clinical and audiological examination was done in 2 Belgian families with autosomal dominant sensorineural hearing loss (SNHL) linked to DFNA22. Nineteen subjects in family 1 had mild to moderate SNHL starting in the third decade. The hearing loss was characterized by a flat audiogram affecting all tested frequencies with statistically significant progression. In family 2 eleven subjects were affected with mild to moderate SNHL starting in the second decade. Most of them showed a flat audiogram, but some had mid-frequency hearing loss. Significant progression of thresholds was present at 4 and 8 kHz. For all hitherto known DFNA22 families the audiological and clinical characteristics were correlated with the molecular data. This study describes the phenotype of 2 Belgian families with SNHL linked to DFNA22, both with a pathogenic change in the deafness gene MYO6. The phenotypes of all hitherto reported DFNA22 families with mutations in the MYO6 gene have been studied and compared. It seems that genetic defects that spare the motor domain of the myosin VI protein have a milder phenotype.
References
1.
Ahmed ZM, Morell RJ, Riazuddin S, Gropman A, Shaukat S, Ahmad MM, Mohiddin SA, Fananapazir L, Caruso RS, Husnain T, Khan S, Griffith AJ, Friedman TB, Wilcox ER: Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet 2003;72:1315–1322.
2.
Avraham KB, Hasson T, Steel KP, Kingsley DM, Russel LB, Mooseker MS, Copeland NG, Jenkins NA: The mouse Snell’s waltzer deafness gene encodes an unconventional myosin required for the structural integrity of inner ear hear cells. Nat Genet 1995;11:369–375.
3.
Avraham KB, Hasson T, Steel KP, Kingsley DM, Russel LB, Mooseker MS, Copeland NG, Jenkins NA: Characterization of unconventional MYO6, the human homologue of the gene responsible for deafness in Snells’s waltzer mice. Hum Mol Genet 1997;6:1225–1231.
4.
Gibson F, Walsh J, Mburu P, Varela A, Brown KA, Antonio M, Beisel KW, Steel KP, Brown SD: A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995;374:62–64.
5.
Hasson T, Mooseker MS: Porcine myosin-VI: characterization of a new mammalian unconventional myosin. Cell Biol 1994;127:425–440.
6.
Hasson T, Skowron J, Gilbert DJ, Avraham KB, Perry WL, Bement WM, Anderson BL, Sherr EH, Chen ZY, Greene LA, Ward DC, Corey DP, Mooseker MS, Copeland NG, Jenkins NA: Mapping of unconventional myosins in mouse and human. Genomics 1996;36:431–439.
7.
Hilgert N, Topsakal V, Van Dinther J, OE, Van de Heyning P, Van Camp G: A splice site mutation and overexpression of MYO6 cause a similar phenotype in two families with autosomal dominant hearing loss. Eur J Hum Genet 2008;16:593–602.
8.
Huygen PLM, Pennings RJE, Cremers CWRJ: Characterising and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiolol Med 2003;1:37–46.
9.
ISO7029: Acoustsics: Thresholds of Hearing by Air Conduction as a Function of Age and Sex for Otologically Normal Persons, ed 2. Geneva, International Organization for Standardization, 2000.
10.
Leon PE, Raventos H, Lynch E, Morrow J, King MC: The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl Acad Sci USA 1992;89:5181–5184.
11.
Lynch ED, Lee MK, Morrow JE, Welcsh PL, Leon PE, King MC: Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science 1997;278:1315–1318.
12.
Melchionda S, Nadav A, Bisceglia L, Sobe T, Glaser F, Rabionet R, Arbones ML, Notarangelo A, Di Lorio E, Carell M, Zelante L, Estivill X, Avraham KB, Gasparini P: MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet 2001;69:635–640.
13.
Mermall V, Post PL, Mooseker MS: Unconventional myosins in cell movement, membrane traffic and signal transduction. Science 1998;279:527–533.
14.
Mohiddin SA, Ahmed ZM, Griffith AJ, Tripodi D, Friedman TB, Fananapazir L, Morell RJ: Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet 2004;41:309–314.
15.
Plantinga RF, de Brouwer AP, Huygen PL, Kunst HP, Kremer H, Cremers CW: A novel TECTA mutation in a Dutch DFNA8/12 family confirms genotype-phenotype correlation. J Assoc Res Otolaryngol 2006;7:173–181.
16.
Probst FJ, Fridell RA, Raphael Y, Saunders TL, Wang A, Liang Y, Morell RJ, Touchman JW, Lyons RH, Noben-Trauth K, Friedman TB, Camper SA: Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 1998;280:1444–1447.
17.
Sanggaard KM, Kjaer KW, Eiberg H, Nurnberg G, Nurnberg P, Hoffman K, Jensen H, Sorum C, Rendtorff N, Tranebjaerg L: A novel nonsense mutation in MYO6 is associated with progressive nonsyndromic hearing loss in a Danish DFNA22 family. Am J Med Genet A 2008;146:1017–1025.
18.
Smith RJ, Bale JF, White KR: Sensorineural hearing loss in children. Lancet 2005;365:879–890.
19.
Sweeney HL, Houdusse A: What can myosin VI do in cells? Curr Opin Cell Biol 2007;19:57–77.
20.
Topsakal V, Pennings RJE, te Brinke H, Hamel B, Huygen PLM, Kemer H, Cremers CWRJ: Phenotype determination guides swift genotyping of a DFNA2/KCNQ4 family with a hotspot mutation (W276S). Otol Neurotol 2005a;26:52–58.
21.
Topsakal V, Van Camp G, Van de Heyning P: Genetic testing for hearing impairment. B-ENT 2005b;1:125–135.
22.
Van Camp G, Smith R: Hereditary Hearing Loss Homepage. 2009. http://webh01.ua.ac.be/hhh/.
23.
Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S, Lee MK, Kanaan M, King MC, Avraham KB: From flies’ eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci USA 2002;99:7518–7523.
24.
Wang A, Liang Y, Fridell RA, Probst FJ, Wilcox ER, Touchman JW, Morton CC, Morell RJ, Noben-Trauth K, Camper SA, Friedman TB: Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 1998;280:1451.
25.
Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD: Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995;374:61.
26.
Weil D, Kussel P, Blanchard S, Levy G, Levi-Acobas F, Drira M, Ayadi H, Petit C: The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997;16:191–193.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
